InvescoHealthPSCH · Nasdaq
Invesco S&P SmallCap Health Care ETF (PSCH)
- Price
- $52.95
- —11 Sept 2026
- Assets
- $183.9M
- Total net assets
- Expense ratio
- 0.29%
- Category 1.00%
- Yield
- 0.01%
- Trailing distributions
- 3Y CAGR
- 10.3%-3.2%
- Category 13.5%
- 5Y CAGR
- -3.1%-5.0%
- Category 1.9%
Loading NAV history…
Invesco S&P SmallCap Health Care ETF
Calendar-year returns
Fund only: no comparison series covers this fund's history.
Risk statistics
Five years of daily closes. Risk-free rate 4% a year.
- Standard deviation
- —
- Maximum drawdown
- —
- Sharpe ratio
- —
- Sortino ratio
- —
- Beta
- —
- Alpha
- —
- R²
- —
- Information ratio
- —
- Upside capture
- —
- Downside capture
- —
- Tracking error
- —
Holdings
The 10 largest positions make up 37.6% of the fund.
Top holdings
| Ticker | Holding | Weight |
|---|---|---|
| CORT | Corcept Therapeutics Inc | 5.52% |
| GKOS | Glaukos Corp | 5.38% |
| PTGX | Protagonist Therapeutics Inc | 4.55% |
| ALKS | Alkermes PLC | 3.99% |
| TGTX | TG Therapeutics Inc | 3.65% |
| TFX | Teleflex Inc | 3.21% |
| PTCT | PTC Therapeutics Inc | 2.94% |
| LGND | Ligand Pharmaceuticals Inc | 2.90% |
| MMSI | Merit Medical Systems Inc | 2.76% |
| RDNT | RadNet Inc | 2.74% |
Portfolio valuation
Weighted averages of what the fund holds.
- P/E
- 26.5
- P/B
- 3.1
- P/S
- 2.2
- P/CF
- 15.7
Sector allocation
Share of the equity the fund holds.
- Health care98.9%
- Financial services1.1%
Asset mix
- Stocks100.0%
- Cash0.0%
ETF details
- Issuer
- Invesco
- Category
- Equity · Health
- Ticker
- PSCH
- Exchange
- Nasdaq
- Inception
- 7 Apr 2010 (16.4 years)
- Structure
- Exchange Traded Fund
- Expense ratio
- 0.29% (category 1.00%)
- Holdings turnover
- 42% (category 51%)
- Distribution yield
- 0.01%
- Beta, 3 years
- 0.93
- Total net assets
- $183.9M
Prices and returns as of 11 Sept 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.
Other health ETFs
Other ETFs in the Health category.
- XHE · State Street SPDR S&P Health Care Equipment ETFState Street Investment Management · $180.7M · ER 0.35%5Y -7.1%
- LFSC · F/M Emerald Life Sciences Innovation ETFEmerald Mutual Fund Advisers Trust · $126.3M · ER 0.54%
- BBP · Virtus Biotech ETFVirtus · $116.8M · ER 0.34%5Y 14.8%
- GNOM · Global X Genomics & Biotechnology ETFGlobal X Funds · $91.9M · ER 0.50%5Y -8.0%
- HTEC · ROBO Global Healthcare Technology and Innovation ETFRobo Global · $76.5M · ER 0.68%5Y -3.4%
- HRTS · Tema Heart & Health ETFTema ETFs · $55.6M · ER 0.75%